The early detection and prompt treatment ofpotentially life-threatening PCa is key to any policy aimed at reducing mortality.However, screening asymptomatic men using the serum prostate-specific antigen (PSA)test is a contentious public health issue. This evidence concerns the gene KLK3 and posterior cortical atrophy.